Locations:
Search IconSearch

Tag: gynecologic cancers

Ovarian tumor

PARP Inhibitors Decrease Response to Subsequent Platinum-Based Chemotherapy in Recurrent Ovarian Cancer

Analysis suggests association between prior PARP inhibition and subsequent decreased progression-free survival in platinum-sensitive ovarian cancer

translational-research_650x450

Cleveland Clinic Forms Center for Research Excellence in Gynecologic Cancer

Developing and delivering the care most needed by patients, now

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad